Stock Fundamentals

Company Information

Company Name
TIANJIN PHARM DA REN TANG GRP
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
SG
Currency: USD
Full Time Employees: 3,890
Phone: 86 22 2702 0892
Fiscal Year End: December
Description:

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.

Address:

No. 17, Baidi Road, Tianjin, China, 300193

Directors & Officers

Name Title Year Born
Ms. Lei Wang Chairman of the Board 1971
Mr. Jian Ma Chief Financial Officer 1978
Mr. Hong Zhou Deputy GM, Chief Engineer & Executive Director 1970
Mr. Min Guo Executive Director 1971
Mr. Yu Zhang Chief Manufacturing Officer 1973
Mr. Mingjie Shang Employee Director 1969
Ms. Yan Jiao Secretary to the Board of Directors 1977
Tang Chao Accounting Supervisor NA
Mr. Hong Chen Executive Vice President 1971

Shares Statistics

Shares Outstanding: 200.00M
Shares Float: 426.53M
% Insiders: 880.00%
% Institutions: 16.00%

Valuation Metrics

Enterprise Value: $3.73B
Trailing P/E: 7.43
Forward P/E: 14.90

Financial Highlights

Market Cap: $4.03B
EBITDA: $1.13B
P/E Ratio: $7.43
PEG Ratio: $0.00
Book Value: $1.44
Dividend/Share: $4.79
Dividend Yield: 16.86%
Earnings/Share: $0.42
Profit Margin: 43.81%
Operating Margin: 32.97%
ROA (TTM): 5.92%
ROE (TTM): 27.47%
Revenue (TTM): $4.98B
Revenue/Share (TTM): $6.46
Earnings Growth (YOY): 12.20%
Revenue Growth (YOY): 4.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.59x 0.00x 0.39x 105.99x 0.00x
2024-12-31 2.35x 0.00x 0.27x 21.28x 0.00x
2023-12-31 2.03x 0.04x 0.35x 24.22x 0.28x
2022-12-31 2.17x 0.02x 0.35x 70.44x 0.14x
2021-12-31 2.64x 0.00x 0.28x 208.77x 0.00x
2020-12-31 2.59x 0.01x 0.28x 89,479.64x 0.03x
2019-12-31 2.38x 0.01x 0.31x 122.27x 0.04x
2018-12-31 2.50x 0.05x 0.31x 44.78x 0.36x
2017-12-31 2.13x 0.06x 0.32x N/A 0.43x
2016-12-31 2.01x 0.07x 0.35x N/A 0.66x
2015-12-31 2.17x 0.14x 0.35x N/A 1.00x
2014-12-31 1.43x 0.33x 0.46x N/A 2.42x
2013-12-31 1.25x 0.53x 0.51x N/A 3.66x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about T14.SG!